2m 2m 2m 2m 2m 2m 2m
Omnicell (OMCL)
NASDAQ
$39.20+$0.52 (+1.34%)
Price as of Jun 23, 2026 7:17 PM EDT- $1.8BMarket Cap
- 36.34%1-Year Change
- Health Information ServicesIndustry
Omnicell (OMCL)
$39.20+$0.52 (+1.34%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 665.7M -40.15% | 1.1B -3.04% | 1.1B -11.48% | 1.3B +14.48% | |
Cost of Revenue | 379.2M -40.87% | 641.2M -1.39% | 650.3M -8.02% | 707.0M +22.45% | |
Gross Profit | 503.4M +6.89% | 471.0M -5.20% | 496.8M -15.64% | 589.0M +6.19% | |
Sales and Marketing Expense | 409.6M +7.72% | 380.3M -12.50% | 434.6M -10.64% | 486.3M +24.89% | |
Research and Development Expense | -88.7M -1.92% | -90.4M -6.90% | -97.1M -192.52% | 105.0M +38.64% | |
Depreciation and Amortization Expense | 78.8M -4.18% | 82.2M -5.83% | 87.3M +0.45% | 86.9M +19.10% | |
Total Operating Expenses | 498.3M +5.87% | 470.7M -11.48% | 531.7M -10.08% | 591.3M +27.12% | |
Operating Profit | 5.2M +1,431.16% | 337,000 +100.97% | -34.9M +1,400.99% | -2.3M -102.60% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 6.2M -75.59% | 25.3M +71.11% | 14.8M +11,453.85% | -130,000 -99.45% | |
Income before Taxes | 11.3M -55.75% | 25.6M +227.28% | -20.1M +719.73% | -2.5M -103.72% | |
Income Taxes | 9.3M -29.01% | 13.1M +4,866.54% | 263,000 +103.25% | -8.1M -31.59% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 2.1M -83.62% | 12.5M +161.51% | -20.4M -460.68% | 5.6M -92.74% | |
Net Income from Continuing Operations Applicable to Common | 11.3M -55.75% | 25.6M +227.28% | -20.1M +719.73% | -2.5M -103.72% | |
Basic EPS and Net Income | 0.04 -85.19% | 0.27 +160.00% | -0.45 -446.15% | 0.13 -92.74% | |
Diluted EPS and Net Income | 0.04 -85.19% | 0.27 +160.00% | -0.45 -475.00% | 0.12 -92.59% | |
Basic Weighted Average Shares | 46.0M -0.18% | 46.0M +1.85% | 45.2M +1.83% | 44.4M +2.12% | |
Diluted Weighted Average Shares | 46.4M +0.23% | 46.3M +2.31% | 45.2M -1.48% | 45.9M -4.28% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 196.5M -46.77% | 369.2M -21.11% | 468.0M +41.65% | 330.4M -5.35% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 196.5M -46.77% | 369.2M -21.11% | 468.0M +41.65% | 330.4M -5.35% | |
Total Current Assets | 680.1M -16.61% | 815.5M -12.08% | 927.6M +5.19% | 881.8M +12.95% | |
Accumulated Depreciation | 196.5M +16.72% | 168.4M +20.77% | 139.4M +10.10% | 126.6M +3.85% | |
Property and Plant and Equipment and Net | 120.1M +6.58% | 112.7M +3.77% | 108.6M +15.58% | 94.0M +32.08% | |
Total Long-Term Assets | 70.2M -11.48% | 79.3M -12.34% | 90.5M -13.86% | 105.0M -17.65% | |
Total Assets | 2.0B -6.89% | 2.1B -4.76% | 2.2B +0.73% | 2.2B +3.19% | |
Income Taxes Payable | 683,000 -38.36% | 1.1M -31.60% | 1.6M -22.67% | 2.1M -95.95% | |
Total Short-Term Debt | 0 -100.00% | 174.3M N/A | N/A N/A | 0 -100.00% | |
Total Current Liabilities | 476.6M -19.99% | 595.7M +61.96% | 367.8M -14.16% | 428.4M -51.10% | |
Total Long-Term Debt | 167.6M +0.72% | 166.4M -70.79% | 569.7M +0.55% | 566.6M N/A | |
Total Long-Term Liabilities | 10.0M +38.13% | 7.2M +14.25% | 6.3M -5.97% | 6.7M -14.29% | |
Total Liabilities | 742.9M -15.35% | 877.6M -15.44% | 1.0B -3.95% | 1.1B +8.52% | |
Retained Earnings | 384.9M +0.54% | 382.9M +3.38% | 370.4M -5.21% | 390.7M +6.01% | |
Total Stockholders Equity | 1.2B -0.92% | 1.2B +4.57% | 1.2B +5.20% | 1.1B -1.44% | |
Total Shares Outstanding | 45.0M -2.92% | 46.4M +1.85% | 45.5M +1.77% | 44.7M +1.29% | |
Cash Flow | |||||
Cash from Operating Activities | 127.3M -32.19% | 187.7M +3.66% | 181.1M +132.83% | 77.8M -66.45% | |
Capital Expenditures | 40.4M +10.84% | 36.5M -12.08% | 41.5M -12.75% | 47.5M +64.10% | |
Cash from Investing Activities | -60.4M +14.34% | -52.8M -4.04% | -55.0M -6.23% | -58.7M -85.78% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -218.3M -7.33% | -235.6M -1,105.88% | 23.4M +211.77% | -21.0M -144.24% | |
Financials Ratio | |||||
Gross Margin | 43.04% +1.64% | 42.35% -2.23% | 43.31% -4.70% | 45.45% -7.24% | |
Operating Margin | 0.78% +2,458.09% | 0.03% +101.00% | -3.04% +1,595.26% | -0.18% -102.27% | |
Return on Assets | 0.10% -82.62% | 0.58% +162.78% | -0.92% -453.80% | 0.26% -93.39% | |
Return on Equity | 0.17% -83.91% | 1.03% +158.65% | -1.76% -454.12% | 0.50% -93.26% | |
Revenue Growth | -40.15% +1,220.57% | -3.04% -73.53% | -11.48% -179.31% | 14.48% -46.12% | |
Current Ratio | 1.43 +4.23% | 1.37 -45.72% | 2.52 +22.53% | 2.06 +130.97% | |
Cash Ratio | 0.41 -33.48% | 0.62 -51.29% | 1.27 +65.01% | 0.77 +93.55% | |
Debt-to-Equity Ratio | 0.14 -50.33% | 0.27 N/A | N/A N/A | 0.50 +17.76% | |
Debt-to-Assets Ratio | 0.08 -47.14% | 0.16 N/A | N/A N/A | 0.26 +12.51% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow